Guideline for the Stability Testing of Non-Prescription (OTC) Drug Products Not Regulated by an NDA/ANDA
Abstract: From the 36th Annual ASQ/FDC FDA Conference on Quality and Compliance Issues.
Already a member? Access this Content
You will need Adobe Reader to view this PDF document.
Download the free Reader from Adobe
You must log in to comment. Please log in or register. Comments FAQ
